Skip to main content

Table 1 Characteristics comparison before and after matching

From: Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study

Covariates

Before matching at WIHSbenrollment

After matching at index visit

All HAARTcuse women

All HAART naïve women

p-Value

Matched HAART use women

Matched HAART naïve women

p-Value

 

(N = 2053)

(N = 760)

 

(N = 389)

(N = 389)

 

Age, mean (SD a )

35 (7.9)

37 (7.6)

<.0001

39.7 (8.7)

39.4 (8.2)

0.57

Race, N (%)

  

0.015

  

0.81

   White, non-hispanic

308 (15.0)

122 (16.1)

 

57 (14.7)

52 (13.4)

 

   Black, non-hispanic

1119 (54.5)

451 (59.3)

 

233 (59.9)

246 (63.2)

 

   Hispanic

560 (27.3)

162 (21.3)

 

88 (22.6)

80 (20.6)

 

   Other

66 (3.2)

25 (3.3)

 

11 (2.8)

11 (2.8)

 

Education, N (%)

  

0.086

  

0.64

   Less than high school

759 (37.1)

304 (40.1)

 

148 (38.1)

158 (40.6)

 

   Completed high school

612 (29.9)

237 (31.2)

 

126 (32.4)

127 (32.7)

 

   Some college and above

677 (33.1)

218 (28.7)

 

115 (29.6)

104 (26.7)

 

AIDS, N (%)

407 (19.8)

308 (43.08)

<.0001

135 (34.7)

138 (35.5)

0.82

CD4+ cell counts, mean (SD)

430 (291.7)

398 (365.3)

<.0001

372.6 (248.1)

358.7 (279.2)

0.47

CD8+ cell counts, mean (SD)

899.7 (464.1)

792.2 (597.3)

<.0001

847.2 (519.3)

806.8 (521.4)

0.28

log10 (Viral load), mean (SD)

3.9 (1.1)

4.4 (1.2)

<.0001

3.9 (1.1)

4.1 (1.2)

0.14

Quality of life score, mean (SD)

64.8 (20.4)

57.4 (21.2)

0.18

63.8 (21.5)

62.4 (22.2)

0.35

  1. astandard deviation; bWIHS: Women’s Interagency HIV Study; cHAART: highly active anti-retroviral therapy.